Singapore Opioid Pain Management Market Report 2022 to 2030

Singapore Opioid Pain Management Market Analysis

$ 3999

Singapore opioid pain management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Some of the main factors influencing the market's growth include an increase in the use of these painkillers and an increase in the proportion of the elderly population that is particularly susceptible to orthopaedic pain. Additionally, there has been a significant increase in the number of people worldwide who experience chronic pain. The major key players in this market are Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., etc.

ID: IN10SGPH346 CATEGORY: Pharmaceuticals GEOGRAPHY: Singapore AUTHOR: Vidhi Upadhyay

Buy Now

Singapore Opioid Pain Management Market Analysis Summary

Singapore Opioid Pain Management Market is valued at around $51.3 Mn in 2022 and is projected to reach $77.9 Mn by 2030, exhibiting a CAGR of 5.35% during the forecast period 2023-2030.

Particularly in acute and cancer-related pain disorders, opioids are quite effective at reducing moderate to severe pain. They work by activating opioid receptors in the central nervous system, which decreases pain perception and raises pain tolerance. Opioids can improve a patient's quality of life by successfully managing pain and fostering both physical and mental health. Patients can function better overall, engage in everyday activities, and get better sleep with adequate pain management. Extended-release opioid formulations are available, which offer long-lasting pain relief and eliminate the need for regular doses. Patients can maintain steady pain management thanks to this, which also improves treatment compliance. Some of the main factors influencing the market's growth include an increase in the use of these painkillers and an increase in the proportion of the elderly population that is particularly susceptible to orthopedic pain. Additionally, there has been a significant increase in the number of people worldwide who experience chronic pain. The major key players in this market are Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Abbott Laboratories, Purdue Pharma L.P., GlaxoSmithKline Plc, Johnson & Johnson, and F. Hoffmann La Roche Ltd.

Market Dynamics

Market Growth Drivers

Increased use of these painkillers and an increase in the elderly population, which is particularly vulnerable to orthopaedic pain, are the main drivers driving the market's expansion. Additionally, there has been a marked increase in the number of persons worldwide who experience chronic pain. The global opioid market is expected to rise as a result, according to predictions.

Market Restraints

However, it is projected that the global rise in opioid addiction (the "opioid epidemic") and the implementation of strict regulatory rules for an opioid prescription will restrain market growth. Additionally, a significant factor limiting the market's growth is the rise in death rates caused by these medications' overdoses. Additionally, opioids' addictive qualities have resulted in drug abuse while also providing several negative effects, such as fatigue, nausea, constipation, euphoria, confusion, and more.

Competitive Landscape

Key Players

Pfizer, Inc.
Sanofi S.A.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Co.
Abbott Laboratories
Purdue Pharma L.P.
GlaxoSmithKline Plc
Johnson & Johnson
F. Hoffmann La Roche Ltd.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Singapore Opioid Pain Management Market Segmentation

By Product Type

Codeine
Fentanyl
Morphine
Meperidine
Methadone
Tramadol
Other

By Receptor Binding

Strong Agonist
Mild to Moderate Agonist

By Applications

Cancer Pain
Neuropathic Pain
Osteoarthritis Pain
Other Pain Management

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.